Novel targets for immunotherapy in glomerulonephritis. - Wikidata - wikimedia - TriplyDB

Novel targets for immunotherapy in glomerulonephritis.

Novel targets for immunotherapy in glomerulonephritis.

http://www.wikidata.org/entity/Q37290692

about

Review: Complement and its regulatory proteins in kidney diseases.The complement cascade and renal disease.

P2860

Q33647738-E52263DF-4BAE-4658-B9FC-D555AE735CC1 Q37502706-7B08A9B4-F422-4033-8DFF-02860F90E6BC

P2860

Novel targets for immunotherapy in glomerulonephritis.

http://www.wikidata.org/entity/Q37290692

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on September 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Novel targets for immunotherapy in glomerulonephritis.

@en

Novel targets for immunotherapy in glomerulonephritis.

@nl

type

label

Novel targets for immunotherapy in glomerulonephritis.

@en

Novel targets for immunotherapy in glomerulonephritis.

@nl

prefLabel

Novel targets for immunotherapy in glomerulonephritis.

@en

Novel targets for immunotherapy in glomerulonephritis.

@nl

P1433

Q37290692-2E02B7FD-8A39-47D6-A3C1-813C6393D6BB

P1476

Q37290692-FE8B083E-7922-4AA8-9991-7759E80A1022

P2093

Q37290692-F5956566-7DD8-424D-AAE6-57708661C625

P2860

Q37290692-0158DDF0-9534-4681-92EC-FBD5567F8032

Q37290692-0450A88D-1749-45CC-86A7-88F3973B1B15

Q37290692-060CC3F3-06F7-4E1A-BAEF-6D9A3B2EFAAB

Q37290692-10455BB3-3720-47BD-A841-3F2E83785CD9

Q37290692-106E82A3-8ADD-409F-90C1-5BF954B2C0E6

Q37290692-1127C1DF-D132-4F2F-91AE-97B6D5AA3299

Q37290692-1191A631-C265-40A6-8E75-632366BEFA76

Q37290692-143B23C7-3CA6-4E51-B7D5-79C60CE06513

Q37290692-16CCA633-AF31-47F1-AEE6-E1F08D96A75B

Q37290692-177D9D6C-6B2B-4111-945D-AC3984CBF40F

P304

Q37290692-ED8BD761-051A-41DA-B1A2-EB1E4645FFC4

P31

Q37290692-32268756-7710-4061-8CDF-4A485D38EBF7

P356

Q37290692-0CFD939A-F661-4A64-A11B-B8173C76E3EE

P433

Q37290692-AF888E64-9E7B-4042-A1EA-A3E57AF2422D

P478

Q37290692-720770CB-269C-4850-9622-AAE703F09DBA

P577

Q37290692-00BE4390-BCEE-437B-B6F2-F54C22D23D71

P698

Q37290692-E23716F4-D1F6-4F3B-A949-5141A6752AF2

P921

Q37290692-15693A7B-A400-4D69-ADD7-CF77FD2A321C

Q37290692-1EA504F0-BBCD-4F95-A68E-94E717281496

P932

Q37290692-CB921D03-4F1F-4975-AC92-0A81C64E7CCE

P356

P1433

Biologics: Targets and Therapy

P1476

Novel targets for immunotherapy in glomerulonephritis.

@en

P2093

Mary H Foster

http://www.w3.org/2001/XMLSchema#string

P2860

Fcgamma receptors: old friends and new family members

Complement inhibitors targeted to the proximal tubule prevent injury in experimental nephrotic syndrome and demonstrate a key role for C5b-9

Laminin-1 reexpression in Alport mouse glomerular basement membranes

FcgammaRIV: a novel FcR with distinct IgG subclass specificity

Prevalence of chronic kidney disease in the United States

IgG Fc receptors

Antigenic targets in epimembranous glomerulonephritis. Experimental data and potential application in human pathology.

Treatment with a consensus peptide based on amino acid sequences in autoantibodies prevents T cell activation by autoantigens and delays disease onset in murine lupus.

Heterozygous and homozygous factor h deficiencies associated with hemolytic uremic syndrome or membranoproliferative glomerulonephritis: report and genetic analysis of 16 cases.

High-dose intravenous immunoglobulins: an option in the treatment of systemic lupus erythematosus.

P304

531-545

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/BTT.S2764

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

2

http://www.w3.org/2001/XMLSchema#string

P577

2008-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19707383

http://www.w3.org/2001/XMLSchema#string

P921

glomerulonephritis

P932

2721381

http://www.w3.org/2001/XMLSchema#string